SERA PROGNOSTICS, INC. Operating Income
SERA PROGNOSTICS, INC. (SERA) reported Operating Income of -$10.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-12
- SERA PROGNOSTICS, INC. operating income (loss) for the quarter ending 2026-06-30 was -$10.00M.
- SERA PROGNOSTICS, INC. operating income (loss) for the quarter ending 2026-03-31 was -$9.36M.
- SERA PROGNOSTICS, INC. operating income (loss) for the quarter ending 2025-12-31 was -$8.95M.
- SERA PROGNOSTICS, INC. operating income (loss) for the quarter ending 2025-09-30 was -$8.98M.
- SERA PROGNOSTICS, INC. operating income (loss) for fiscal 2025 was -$36.50M.
- SERA PROGNOSTICS, INC. operating income (loss) for fiscal 2024 was -$36.63M.
- SERA PROGNOSTICS, INC. operating income (loss) for fiscal 2023 was -$39.82M.
- SERA PROGNOSTICS, INC. operating income (loss) for fiscal 2022 was -$45.65M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$10.00M 10-Q · filed 2026-08-12 | -$19.36M 10-Q · filed 2026-08-12 | -$28.32M derived: sum of 3 quarters · filed 2026-08-12 | -$37.30M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$9.36M 10-Q · filed 2026-05-06 | -$18.31M derived: sum of 2 quarters · filed 2026-05-06 | -$27.29M derived: sum of 3 quarters · filed 2026-05-06 | -$36.61M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$8.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$17.93M derived: sum of 2 quarters · filed 2026-03-18 | -$27.25M derived: sum of 3 quarters · filed 2026-08-12 | -$36.50M 10-K · filed 2026-03-18 |
| 2025-09-30 | -$8.98M 10-Q · filed 2025-11-13 | -$18.30M derived: sum of 2 quarters · filed 2026-08-12 | -$27.55M 10-Q · filed 2025-11-13 | -$36.97M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$9.32M 10-Q · filed 2026-08-12 | -$18.57M 10-Q · filed 2026-08-12 | -$27.99M derived: sum of 3 quarters · filed 2026-08-12 | -$36.85M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$9.25M 10-Q · filed 2026-05-06 | -$18.67M derived: sum of 2 quarters · filed 2026-05-06 | -$27.54M derived: sum of 3 quarters · filed 2026-05-06 | -$36.79M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$9.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$18.29M derived: sum of 2 quarters · filed 2026-03-18 | -$27.54M derived: sum of 3 quarters · filed 2026-03-18 | -$36.63M 10-K · filed 2026-03-18 |
| 2024-09-30 | -$8.86M 10-Q · filed 2025-11-13 | -$18.11M derived: sum of 2 quarters · filed 2025-11-13 | -$27.21M 10-Q · filed 2025-11-13 | -$36.06M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$9.25M 10-Q · filed 2025-08-06 | -$18.35M 10-Q · filed 2025-08-06 | -$27.20M derived: sum of 3 quarters · filed 2025-08-06 | -$35.38M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$9.10M 10-Q · filed 2025-05-07 | -$17.95M derived: sum of 2 quarters · filed 2025-05-07 | -$26.13M derived: sum of 3 quarters · filed 2025-05-07 | -$37.59M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$8.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$17.03M derived: sum of 2 quarters · filed 2025-03-19 | -$28.49M derived: sum of 3 quarters · filed 2025-03-19 | -$39.82M 10-K · filed 2025-03-19 |
| 2023-09-30 | -$8.18M 10-Q · filed 2024-11-06 | -$19.64M derived: sum of 2 quarters · filed 2024-11-06 | -$30.97M 10-Q · filed 2024-11-06 | -$41.39M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$11.46M 10-Q · filed 2024-08-07 | -$22.79M 10-Q · filed 2024-08-07 | -$33.21M derived: sum of 3 quarters · filed 2024-08-07 | -$44.40M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$11.33M 10-Q · filed 2024-05-08 | -$21.75M derived: sum of 2 quarters · filed 2024-05-08 | -$32.94M derived: sum of 3 quarters · filed 2024-05-08 | -$44.68M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$10.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$21.61M derived: sum of 2 quarters · filed 2024-03-20 | -$33.35M derived: sum of 3 quarters · filed 2024-03-20 | -$45.65M 10-K · filed 2024-03-20 |
| 2022-09-30 | -$11.19M 10-Q · filed 2023-11-08 | -$22.93M derived: sum of 2 quarters · filed 2023-11-08 | -$35.23M 10-Q · filed 2023-11-08 | -$47.78M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$11.75M 10-Q · filed 2023-08-09 | -$24.05M 10-Q · filed 2023-08-09 | -$36.59M derived: sum of 3 quarters · filed 2023-08-09 | -$46.03M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$12.30M 10-Q · filed 2023-05-10 | -$24.85M derived: sum of 2 quarters · filed 2023-05-10 | -$34.29M derived: sum of 3 quarters · filed 2023-05-10 | -$41.67M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$12.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$21.99M derived: sum of 2 quarters · filed 2023-03-22 | -$29.37M derived: sum of 3 quarters · filed 2023-03-22 | -$35.40M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$9.44M 10-Q · filed 2022-11-09 | -$16.82M derived: sum of 2 quarters · filed 2022-11-09 | -$22.85M 10-Q · filed 2022-11-09 | -$27.60M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$7.38M 10-Q · filed 2022-08-10 | -$13.41M 10-Q · filed 2022-08-10 | -$18.16M derived: sum of 3 quarters · filed 2022-08-10 | -$22.80M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$6.03M 10-Q · filed 2022-05-10 | -$10.78M derived: sum of 2 quarters · filed 2022-05-10 | -$15.42M derived: sum of 3 quarters · filed 2022-05-10 | -$19.70M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$9.40M derived: sum of 2 quarters · filed 2022-03-29 | -$13.68M derived: sum of 3 quarters · filed 2022-03-29 | -$17.97M 10-K · filed 2022-03-29 |
| 2020-09-30 | -$4.64M 10-Q · filed 2021-11-09 | -$8.93M derived: sum of 2 quarters · filed 2021-11-09 | -$13.22M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$4.28M 10-Q · filed 2021-08-30 | -$8.57M 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |